全球 Omega-3 市场规模：按类型、原产地、应用、地区、范围和预测

Omega-3 市场规模及预测

2021年Omega-3市场规模为21亿美元，预计2022年至2030年复合年增长率为8.21%，到2030年将达到39.3亿美元。消费者对健康饮食和 omega-3 健康益处的认识不断提高，以及临床研究和开发投资的增加，预计将在预计的几年内推动 omega-3 市场的发展。 Omega-3 全球市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球 omega-3 市场的定义

Omega-3 脂肪酸可降低心臟病的风险并促进皮肤健康。当饮食和运动结合时，omega-3 脂肪酸可以降低血脂（三酸甘油酯）水平并增加 "好" 胆固醇（HDL）水平。它也用于促进高血压和自体免疫疾病。随着慢性病的增加，omega-3 市场不断改变。它被归类为支持 omega-3 脂肪酸 (DHA)、omega-3 (EPA) 和 omega-3 (ALA)。

全球 omega-3 市场概况

预计未来几年，消费者对健康饮食和多元不饱和脂肪酸健康边缘的认识不断增强，以及对临床分析和市场开发领域单位的投资不断增加，预计将促进 omega-3 市场的发展。此外，产品中活性药物成分 (API) 的使用不断增加以及人们对慢性病的认识不断增强，预计将在未来几年提振市场。

此外，Omega-3 增强免疫力和预防慢性疾病（如狗和猫的恶性疾病和发炎性内臟疾病）的能力预计将在预测期内推动市场发展。还有两方面的挑战可能阻碍市场成长。严格的监管障碍和 omega-3 单位面积的更好价格等因素无疑是市场阻碍因素。

目录

第1章全球 omega-3 市场简介

• 市场概览
• 调查范围
• 先决条件

第 2 章执行摘要

第3章验证市场情报研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第4章全球 Omega-3 市场展望

• 摘要
• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 波特的五力模型
• 价值链分析

第 5 章全球 omega-3 市场（按类型）

• 摘要
• 二十二碳六烯酸 (DHA)
• 二十碳五烯酸 (EPA)
• ALPHA-亚麻油酸（Ala）

第 6 章 omega-3 的全球市场：依来源划分

• 摘要
• 海洋起源
• 植物性

第 7 章 Omega-3 全球市场，依应用划分

• 摘要
• 营养补充品
• 功能性食品和饮料
• 医学
• 其他

第 8 章按地区划分的全球 Omega-3 市场

• 摘要
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东/非洲

第9章全球omega-3市场竞争态势

• 摘要
• 公司市场排名
• 主要发展策略

第10章公司简介

• CRODA INTERNATIONAL
• DSM
• LONZA
• ORKLA HEALTH
• CARGILL
• CORBION
• GC RIEBER
• BASF
• KD PHARMA
• EPAX

第11章 附录

• 关联调查

Omega 3 Market Size And Forecast

Omega 3 Market size was valued at USD 2.10 Billion in 2021 and is projected to reach USD 3.93 Billion by 2030 , growing at a CAGR of 8.21% from 2022 to 2030. Rising awareness regarding healthy eating & health benefits of omega-3 among consumers and increasing investment in clinical research & development are expected to drive the Omega 3 Market over the predicted years. The Global Omega 3 Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Omega 3 Market Definition

Omega-3 fatty acids facilitate cut back the danger of cardiopathy and promote healthy skin. This area unit intake in conjunction with diet and exercise to assist lower levels of sure blood fat (triglyceride) and boost levels of "good" cholesteric (HDL). Moreover, it's conjointly wanted to facilitate high-pressure or autoimmune disorders. The ever-changing manner, in conjunction with rising chronic diseases, has contributed to the expansion of the Omega 3 Market. It's classified as supporting the sort together with omega-3 fatty acid (DHA), omega-3 (EPA), and omega-3 (ALA).

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Omega 3 Market Overview

Rising awareness relating to healthy feeding & healthy edges of polyunsaturated fatty acid among customers and increasing investment in clinical analysis & development area units are expected to drive the Omega-3 Market over the expected years. Also, the growing product usage within the Active Pharmaceutical Ingredient (API) and rising awareness of chronic diseases expect to lift the market within the coming years.

Additionally, the power of omega-3 to boost immunity & forestall chronic conditions like malady} & inflammatory internal organ disease in cats and dogs is foretold to fuel the market throughout the forecasted period. There are area unit sure restraints and challenges two-faced which might hinder the market growth. Factors like strict regulation barriers and better prices related to omega-three area units doubtless act as market restraints.

Global Omega 3 Market: Segmentation Analysis

The Global Omega 3 Market is Segmented on the basis of Type, Source, Application, and Geography.

Omega 3 Market, By Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-linolenic Acid (ALA)
• Based on Type, the market is segmented into
• Docosahexaenoic Acid (DHA)
• , Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA). Docosahexaenoic Acid (DHA) is predicted to carry the most important market share because of the growing demand for kid formula, which helps in memory retention and learning. Also, it plays a significant role in developing nerve and eye tissues. Global Omega 3 Market, by source

Omega 3 Market, By Source

• Marine Source
• Plant Source

Based on Source, the market is segmented into Marine Source and Plant Source. The marine supply is foretold to carry the foremost important CAGR within the forecasted period as DHA and Environmental Protection Agency area unit synthesized by living thing marine organisms like planktons & Protoctista. The consumption of those organisms helps accumulate polyunsaturated fatty acid fatty acids within the body.

Omega 3 Market, By Application

• Dietary Supplements
• Functional Food & Beverages
• Pharmaceuticals
• Others
• Based on Application, the market is segmented into
• Dietary Supplements
• , Functional Food & Beverages, Pharmaceuticals, and Others. Dietary supplements are units anticipated to own the very best CAGR within the forecasted amount as they're targeted sources of nutrients or alternative substances with an organic process or physiological result.

Omega 3 Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Omega 3 Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The most important share within the market will be dominated by the Asia Pacific, attributable to the upper demand for fortified food products and the advancements in food technology.

Key Players

• The "Global Omega 3 Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Croda International, DSM, Lonza, Orkla Health, Cargill, Corbion, GC Rieber, BASF, KD Pharma, and EPAx.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Partnerships, Collaborations and Agreements
• On November 2020, Croda International had inked a collaborative partnership with Anomera, an innovative green chemistry Canadian company based in Quebec, focused on developing high-quality Carboxylated Cellulose Nanocrystals which are converted into a micron-sized powder.
• On January 2021, Croda International Plc, the specialty chemical company that uses innovative science to create high-performance ingredients and technologies that improve lives, announced a global sales and marketing agreement with Genesis Biosciences. This new partnership further expands Croda's existing portfolio of safe and sustainable cleaning raw materials.
• On June 2021, Lonza and Moderna Announced a Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands. A new drug substance production line at Lonza's site in Geleen, Netherlands, will complement the existing production network and support the manufacture of up to an additional 300 million doses per year.
• On July 2021, Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain to manufacture an antibody-drug conjugate for use against hard-to-treat cancers.
• Mergers and Acquisitions
• On April 2021, The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The acquisitions give KD Pharma access to technology for producing Active Pharmaceutical Ingredients based on phytocannabinoids and other plant extracts.
• On June 2021, Orkla Health acquired NutraQ, and The acquisition will offer Orkla exciting growth opportunities. The health category and direct-to-consumer sales are growing areas and will continue to develop NutraQ's vital concepts while also exploring new possibilities for direct-to-consumer sales.
• On August 2021, Corbion announced it had acquired Granolife, a Queretaro, Mexico-based provider of functional blends for the Mexican bakery and fortification industries. Granolife employs approximately 60 at its production facility and application in the development center.
• Product Launches and Product Expansions
• On January 2021, Corbion increased its capacity for producing lactic acid in North America by around 40% to meet the growing demand for natural ingredients in multiple industries. The investment reinforces the company's leadership position as a supplier of lactic acid and its derivatives worldwide. Corbion also operates lactic acid production facilities in the Netherlands, Brazil, Spain, and Thailand.

TABLE OF CONTENTS

1 INTRODUCTION TO GLOBAL OMEGA 3 MARKET

• 1.1 OVERVIEW OF THE MARKET
• 1.2 SCOPE OF REPORT
• 1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 DATA MINING
• 3.2 VALIDATION
• 3.3 PRIMARY INTERVIEWS
• 3.4 LIST OF DATA SOURCES

4 GLOBAL OMEGA 3 MARKET OUTLOOK

• 4.1 OVERVIEW
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
  • 4.2.2 RESTRAINTS
  • 4.2.3 OPPORTUNITIES
• 4.3 PORTERS FIVE FORCE MODEL
• 4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OMEGA 3 MARKET, BY TYPE

• 5.1 OVERVIEW
• 5.2 DOCOSAHEXAENOIC ACID (DHA)
• 5.3 EICOSAPENTAENOIC ACID (EPA)
• 5.4 ALPHA-LINOLENIC ACID (ALA)

6 GLOBAL OMEGA 3 MARKET, BY SOURCE

• 6.1 OVERVIEW
• 6.2 MARINE SOURCE
• 6.3 PLANT SOURCE

7 GLOBAL OMEGA 3 MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 DIETARY SUPPLEMENTS
• 7.3 FUNCTIONAL FOOD & BEVERAGES
• 7.4 PHARMACEUTICALS
• 7.5 OTHERS

8 GLOBAL OMEGA 3 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 REST OF THE WORLD
  • 8.5.1 LATIN AMERICA
  • 8.5.2 MIDDLE EAST & AFRICA

9 GLOBAL OMEGA 3 MARKET COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING
• 9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

• 10.1 CRODA INTERNATIONAL
  • 10.1.1 OVERVIEW
  • 10.1.2 FINANCIAL PERFORMANCE
  • 10.1.3 PRODUCT OUTLOOK
  • 10.1.4 KEY DEVELOPMENTS
• 10.2 DSM
  • 10.2.1 OVERVIEW
  • 10.2.2 FINANCIAL PERFORMANCE
  • 10.2.3 PRODUCT OUTLOOK
  • 10.2.4 KEY DEVELOPMENTS
• 10.3 LONZA
  • 10.3.1 OVERVIEW
  • 10.3.2 FINANCIAL PERFORMANCE
  • 10.3.3 PRODUCT OUTLOOK
  • 10.3.4 KEY DEVELOPMENTS
• 10.4 ORKLA HEALTH
  • 10.4.1 OVERVIEW
  • 10.4.2 FINANCIAL PERFORMANCE
  • 10.4.3 PRODUCT OUTLOOK
  • 10.4.4 KEY DEVELOPMENTS
• 10.5 CARGILL
  • 10.5.1 OVERVIEW
  • 10.5.2 FINANCIAL PERFORMANCE
  • 10.5.3 PRODUCT OUTLOOK
  • 10.5.4 KEY DEVELOPMENTS
• 10.6 CORBION
  • 10.6.1 OVERVIEW
  • 10.6.2 FINANCIAL PERFORMANCE
  • 10.6.3 PRODUCT OUTLOOK
  • 10.6.4 KEY DEVELOPMENTS
• 10.7 GC RIEBER
  • 10.7.1 OVERVIEW
  • 10.7.2 FINANCIAL PERFORMANCE
  • 10.7.3 PRODUCT OUTLOOK
  • 10.7.4 KEY DEVELOPMENTS
• 10.8 BASF
  • 10.8.1 OVERVIEW
  • 10.8.2 FINANCIAL PERFORMANCE
  • 10.8.3 PRODUCT OUTLOOK
  • 10.8.4 KEY DEVELOPMENTS
• 10.9 KD PHARMA
  • 10.9.1 OVERVIEW
  • 10.9.2 FINANCIAL PERFORMANCE
  • 10.9.3 PRODUCT OUTLOOK
  • 10.9.4 KEY DEVELOPMENTS
• 10.10 EPAX
  • 10.10.1 OVERVIEW
  • 10.10.2 FINANCIAL PERFORMANCE
  • 10.10.3 PRODUCT OUTLOOK
  • 10.10.4 KEY DEVELOPMENTS

11 APPENDIX

• 11.1 RELATED RESEARCH